Table 2.
Inflammation parameters of control subjects and patients with type 2 diabetes mellitus, according LDL subfraction phenotype, at baseline: T2D: type 2 diabetes
| T2D (N = 122) | T2D phenotype A (N = 77) | T2D phenotype B (N = 45) | Control group (N = 54) | |
|---|---|---|---|---|
| C-reactive protein (mg/l) |
4.49 ± 4.67 a |
4.31 ± 4.52 |
4.86 ± 5.10 |
2.38 ± 3.30 |
| Interleukin-6 (ng/l) |
1.84 ± 3.99 |
2.24 ± 4.95 |
1.17 ± 0.83 |
1.25 ± 1.05 |
| Interleukin-8 (ng/l) |
15.91 ± 12.85 |
17.46 ± 13.74 |
13.20 ± 10.87 |
12.58 ± 9.29 |
| Transforming growth factor β1 (ng/l) |
41.19 ± 30.08 |
31.35 ± 33.74 |
53.92 ± 52.82 b |
39.55 ± 42.86 |
| Monocyte chemotactic protein 1 (ng/l) |
198.0 ± 132.9 a |
190.6 ± 125.6 |
212.1 ± 146.21 |
154.3 ± 83.0 |
| Leptin (ng/l) |
8980 ± 8194 |
9066 ± 8786 |
8787 ± 7184 |
7819 ± 5866 |
| Adiponectin (ng/l) | 3272.0 ± 2671 a | 3663 ± 3044 | 2723 ± 1776 b | 5369 ± 3297 |
Data are expressed mean ± SD.
a, P <0.05 vs control group; b, P <0.05 vs phenotype A patients.